Close
0
Inquiry Basket

There is no product in the shopping cart, buy it!

Hot Products
Monosaccharide Products
Oligosaccharide Products
Polysaccharide Products
Carbohydrate-based Surfactant Products
Blood Group Antigen Products
Glycoprotein Products
Glycopeptide Products
Nucleotide Sugar Products
Glycoprotein Assay Kits
Comprehensive Glycoprotein Reagents
Glycoengineered Cell Products
Glycoengineering Viral Particle Products
Glycolipid Products

Recombinant SARS coronavirus Tor2 Spike glycoprotein (Ser14-Lys1193) [His tag] CHO

CAT#: GP05-380J

Datasheet Request COA
Specifications Target Information Related Products
Specifications
Product Overview
Recombinant SARS coronavirus Tor2 Spike glycoprotein (YP_009825051.1) (Ser14-Lys1193) was produced in CHO cells6-His tag at the C-terminus. Measured by its binding ability in a functional ELISA with recombinant human ACE-2.
Biological Activity
Measured by its binding ability in a functional ELISA with recombinant human ACE-2.
Source
CHO cells
Species
SARS coronavirus Tor2
Fragment
Ser14-Lys1193
Tag
6-His tag at the C-terminus
Predicted N Terminal
Ser14
Predicted MW
136 kDa
Purity
>95%, determined by SDS-PAGE.
Endotoxin Level
<0.1 EU/μg, determined by LAL method.
Conjugation
Unconjugated
Target Information
Target
S
Full Name
Spike glycoprotein
Gene ID
1489668
Accession Number
YP_009825051.1
Background
The spike (S) protein of SARS coronavirus Tor2 is considered as a protective Ag for vaccine design.
Alternate Names
E2
For Research Use Only.
Online Inquiry
Copyright © Creative Biolabs. All Rights Reserved.